Conar Fitton, MD

A panel of experts discuss their key takeaways and the future of treating opioid-induced constipation.

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, discuss a multidisciplinary approach to treating patients with opioid-induced constipation.

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, share their thoughts on how to bring awareness to opioid-induced constipation.

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, discuss managing adverse events that stem from using peripheral μ-opioid receptor antagonists to treat opioid-induced constipation.

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, consider potential patient preferences when choosing oral vs subcutaneous peripheral μ-opioid receptor antagonists.

A multidisciplinary panel shares individual experience with using oral peripherally acting μ-opioid receptor antagonists in managing opioid-induced constipation.

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, review the rationale for the use of μ-opioid receptor agonists for the treatment of opioid-induced constipation.

Experts in gastroenterology review the challenges associated with switching therapies during inpatient and outpatient care for patients with opioid-induced constipation.

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, discuss the multidisciplinary approaches to selecting therapies for patients with opioid-induced constipation.

A multidisciplinary panel shares practical approaches to treating patients with opioid-induced constipation and challenges with patient communication.

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, reviews the position of pharmacies in providing patients with opioid-induced constipation with the necessary medication to decrease hospitalization and cost of medication.

Experts in gastroenterology discuss the quality of life and perspective of patients with opioid-induced constipation.

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, explore the importance of early intervention and the overall challenges of ensuring that patients receive appropriate care for opioid-induced constipation.

A multidisciplinary panel discusses the presentation, frequency, and burden of opioid-induced constipation.